Qiagen stock heads into the open after a 1.7% Frankfurt gain
Published on 09/17/2026 at 08:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Qiagen stock closed at EUR 37.03 on the Frankfurt regulated market on September 16, 2026, marking a 1.67% gain for the session. The shares moved between a low of EUR 36.42 and a high of EUR 37.12, with the advance outpacing the 0.53% rise in the DAX index on the same day.
September 16, 2026 in numbers
Qiagen N.V. (ISIN NL0012169213, NYSE: QGEN) saw its Frankfurt listing finish at EUR 37.03 on September 16, 2026, up from a prior close of EUR 36.42, corresponding to a 1.67% daily increase per Frankfurt exchange data cited by finanzen.net. In that session the intraday range stretched from EUR 36.42 at the low to EUR 37.12 at the high, indicating moderate upside momentum within the day. On the same date, the DAX benchmark gained 0.53% to 25,537.75 points, meaning Qiagen outperformed the broader German blue-chip index in percentage terms.
In parallel with the price move, a new voting rights announcement was released in Frankfurt on September 16, 2026, stating that BlackRock held a combined 12.91% of voting rights in Qiagen through various entities and instruments. As Deutsche Boerse reported in the release, the total holding comprised 9.84% indirect real voting rights and 3.07% indirect potential voting rights via financial instruments, underlining BlackRock's role as a major shareholder. A follow-up disclosure updated the aggregated capital and voting interests held by BlackRock to levels around 11.57% of capital and 12.98% of voting rights, reinforcing the picture of a significant institutional stake in the company, according to a second announcement carried by Deutsche Boerse.
Today’s drivers and events
Heading into today, September 17, 2026, the fresh information about BlackRock's substantial stake and voting rights in Qiagen remains a key backdrop for the stock, as highlighted by coverage noting the asset manager's emergence as a major shareholder. TipRanks pointed out that the AFM disclosure of BlackRock's position underscored strong institutional interest in Qiagen and referenced a recent Buy rating with a USD 42.00 price target on the NYSE-listed shares, which may continue to frame sentiment today. Broader European equity markets also ended in positive territory on September 16, 2026 ahead of an upcoming Federal Reserve decision, with regional indices supported by retreating oil prices and selective gains in technology-linked names, according to Borsa Italiana Radiocor. That supportive market tone and the focus on the Fed's upcoming rate decision could influence trading in Qiagen today, given the stock's sensitivity to global risk appetite and healthcare sector valuations.
